SCOPE of Pain can be used to count toward the DEA licensure 8-hour training requirement as noted in their 3/27/2023 communication as it aligns with SAMHSA's content recommendations required by the 2022 Medication Access and Training Expansion (MATE) Act.
These 2½- to 3-hour meetings will address the core SCOPE of Pain content, and often include additional content specific to the municipality, region, state, and/or institution serving as collaborating partner.
GET STARTED NOW! Select a conferenceDaniel P. Alford, MD, MPH
Professor of Medicine
Associate Dean, Continuing Medical Education
Boston University Chobanian & Avedisian School of Medicine
SCOPE of Pain is a series of continuing education activities designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics. Through the case of Michelle Jones, a 36-year-old who has a displaced right femoral neck fracture due to a motor vehicle crash, you'll learn how to:
Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain.
This activity was planned in collaboration with the Federation of State Medical Boards.
Credit hours will vary depending upon the length of the meeting. Please see registration page for maximum credit amounts.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
These live activities have been approved for AMA PRA Category 1 Credit™.
The AAFP has reviewed SCOPE of Pain: Safer/Competent Opioid Prescribing Education, and deemed it acceptable for AAFP credit. Term of approval is from 9/19/2024-9/19/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
This activity is approved for 2.5 CPE credit(s) under ACPE universal activity number(s):
| Activity date | Universal activity number (UAN) |
|---|---|
| Dec 10, 2024 | JA0000185-0000-24-024-L08-P |
| Jan 25, 2025 | JA0000185-0000-25-001-L08-P |
| Feb 22, 2025 | JA0000185-0000-25-002-L08-P |
| Mar 19, 2025 | JA0000185-0000-25-003-L08-P |
The activity is available for credit claiming for up to 60 days after the date of the activity.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
SCOPE of Pain
© 2024 Trustees of Boston University. Site by Root802.
Overview